Beyond Tumor Treating Fields: Multimodal Antitumor Action and the Clinical Potential of Pulsed Electromagnetic Fields
Abstract
Pulsed electromagnetic fields (PEMFs) are a noninvasive, safe, and well-tolerated physical therapy modality with established applications in musculoskeletal disorders. Their potential role in oncology has attracted increasing interest. This review synthesizes current evidence on the antitumor mechanisms and experimental effects of PEMFs across diverse cancer models. Reported biological effects include the induction of apoptosis, regulation of intracellular calcium homeostasis, inhibition of angiogenesis, modulation of immune responses, induction of oxidative stress, regulation of autophagy and cellular metabolism, and enhancement of sensitivity to radiotherapy and chemotherapy. Preclinical studies suggest that PEMFs can selectively suppress proliferation and promote cell death in malignant cells while exerting comparatively limited cytotoxicity in normal cells. Evidence has been reported in models of breast cancer, glioma, hepatocellular carcinoma, melanoma, and other malignancies. Although clinical investigations remain preliminary, studies conducted over the past two decades support a favorable safety profile and suggest potential therapeutic efficacy, particularly in combination with chemotherapy, radiotherapy, or immunotherapy. Artificial intelligence and machine learning may facilitate parameter optimization and the development of individualized treatment regimens. Ultimately, the integration of PEMFs into routine oncology practice will require well-designed, large-scale randomized controlled trials to standardize treatment protocols, define clinical indications, and establish their role in multimodal cancer care.
AI evidence extraction
Main findings
The review reports that preclinical PEMF studies suggest suppressed malignant-cell proliferation and increased cell death, with comparatively limited cytotoxicity in normal cells. Clinical investigations remain preliminary but suggest a favorable safety profile and potential therapeutic efficacy, particularly alongside other cancer treatments.
Outcomes measured
- Cancer cell proliferation and death
- Antitumor mechanisms
- Sensitivity to chemotherapy and radiotherapy
- Clinical safety and potential efficacy
Limitations
- Clinical investigations remain preliminary
- Large-scale randomized controlled trials are needed
- Treatment protocols and clinical indications are not yet established
View raw extracted JSON
{
"study_type": "review",
"exposure": {
"band": null,
"source": "pulsed electromagnetic fields (PEMFs)",
"frequency_mhz": null,
"sar_wkg": null,
"duration": null
},
"population": "Cancer models; patients in preliminary clinical investigations",
"sample_size": null,
"outcomes": [
"Cancer cell proliferation and death",
"Antitumor mechanisms",
"Sensitivity to chemotherapy and radiotherapy",
"Clinical safety and potential efficacy"
],
"main_findings": "The review reports that preclinical PEMF studies suggest suppressed malignant-cell proliferation and increased cell death, with comparatively limited cytotoxicity in normal cells. Clinical investigations remain preliminary but suggest a favorable safety profile and potential therapeutic efficacy, particularly alongside other cancer treatments.",
"effect_direction": "benefit",
"limitations": [
"Clinical investigations remain preliminary",
"Large-scale randomized controlled trials are needed",
"Treatment protocols and clinical indications are not yet established"
],
"evidence_strength": "low",
"confidence": 0.939999999999999946709294817992486059665679931640625,
"peer_reviewed_likely": "yes",
"keywords": [
"pulsed electromagnetic fields",
"PEMF",
"cancer",
"oncology",
"antitumor effects",
"combination therapy"
],
"suggested_hubs": []
}
AI can be wrong. Always verify against the paper.
Comments
Log in to comment.
No comments yet.